← Back to home

Document DOJ-OGR-00025695

AI Analysis

Summary: An email chain between Charisma Edge, Associate Warden at MCC New York, and [b)(6); (b)(7)(C)], Chief Psychologist, discussing a document related to Epstein's case, its signing, and a reconstruction meeting.
Significance: This email chain is potentially important as it relates to the response to Jeffrey Epstein's situation at MCC New York, possibly regarding his death or a related incident.
Key Topics: Epstein Response Reconstruction meeting Document signing
Key People:
  • [b)(6); (b)(7)(C)] - Chief Psychologist at MCC New York
  • Charisma Edge - Associate Warden at MCC New York

Full Text

Page 1645 Re: Epstein Response From Charisma Edge To [b)(6); (b)(7)(C)] Date 2019/11/13 09:07 Subject: Re: Epstein Response Attachments: TEXT.htm, Charisma Edge.vcf 10-4 Charisma Edge Associate Warden MCC New York 150 Park Row New York, NY 10007 646-836-6300 ext [b)(6); (b)(7)(C)] [b)(6); (b)(7)(C)] op.gov NYM/AW-Programs~@bop.gov >> [b)(6); (b)(7)(C)] 11/13/2019 9:06 AM >>> he hasn't read it yet, I just calle [b)(6); (b)(7)(C)] [b)(6); (b)(7)(C)] Psy.D. Chief Psychologist U.S. Department of Justice/ Federal Bureau of Prisons Metropolitan Correctional Center 150 Park Row New York, New York 10007 Office: (646) 836 [b)(6); (b)(7)(C)] Fax: (646) 836-7712 E-mail: [b)(6); (b)(7)(C)] @bop.gov If you are emailing about an inmate that may be at risk for suicide or self-harm, this is an emergency situation. Please make sure that you make contact (verbally) to Psychology Staff or the on-call psychologist. Please ensure to maintain constant visual observation of the inmate until formal steps can be taken to ensure his/her safety pending a formal assessment by a Psychologist. >>> Charisma Edge 11/13/2019 9:00 AM >>> Yes, I signed it and placed it in the warden's out-box. Double check w him, please so we can have it during the reconstruction meeting. Thanks Charisma Edge Associate Warden MCC New York 150 Park Row New York, NY 10007 646-836-6300 ext [b)(6); (b)(7)(C)] Page 8278 DOJ-OGR-00025695